To examine the relationship between race and mortality in frail community-dwelling older people with access to a program providing comprehensive access and coordination of services. DESIGN: A longitudinal cohort study. SETTING: Twelve nationwide demonstration sites of the Program of All-Inclusive Care for the Elderly (PACE) from 1990 to 1996. PACE provides comprehensive medical and long-term care services for nursing home-eligible older people who live in the community. PARTICIPANTS: Two thousand two white patients and 859 black patients. MEASUREMENTS: Patients were followed after enrollment until death or the end of the follow-up period. Time from enrollment to death was measured with adjustment of the Cox proportional hazards model for comorbid conditions, functional status, site, and other demographic characteristics. RESULTS: Black patients were younger than white patients (mean age 77 vs 80, P Ͻ .001) but had worse functional status (mean activity of daily living (ADL) score 6.5 vs 7.2, P Ͻ .001) on enrollment. Survival for black and white patients was 88% and 86% at 1 year, 67% and 61% at 3 years, and 51% and 42% at 5 years, respectively (unadjusted hazard ratio (HR) for black patients ϭ 0.77; 95% confidence interval (CI) ϭ 0.67-0.89). After adjustment for baseline comorbid conditions, functional status, site, and demographic characteristics, black patients still had a lower mortality rate (HR ϭ 0.77; 95% CI ϭ .65-0.93). The survival advantage for black patients did not emerge until about 1 year after PACE enrollment (HR for first year after enrollment ϭ 0.97; 95% CI ϭ 0.72-1.31; HR after first year ϭ 0.67; 95% CI ϭ 0.54-0.85, P -value for time interaction Ͻ .001). During the first year of enrollment, black patients were more likely to improve and less likely to decline in ADL function than white patients ( P Ͻ .001). CONCLUSION: In PACE, a system providing access to and coordination of comprehensive medical and long-term care services for frail older people, black patients have a lower mortality rate than white patients. This survival advantage, which emerges approximately 1 year after PACE enrollment, may be related to the comprehensive access and coordination of services provided by the PACE program. J Am Geriatr Soc 51:246-251, 2003.
lack patients receive less health care than white patients with the same diagnosis [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] and experience higher mortality for many diseases. 2, 5, [13] [14] [15] [16] [17] However, a few studies have noted better survival, in that defined groups of black patients that have obtained access to treatment for a disease or episode of illness. 6, 11, [18] [19] [20] [21] [22] [23] This black survival advantage has tended to be observed in three healthcare settings: in patients after acute hospitalization, 6, 18, 19, 21 in patients enrolled in Medicare hemodialysis, 11, 20, 23 and in patients enrolled in the Department of Veterans Affairs. 19 The presence of racial differences in health outcomes has never been examined in frail community-dwelling older people. This population is of particular importance because it is growing rapidly, and most frail older people who qualify for nursing home care continue to live at home. 24 Frail community-dwelling older people depend on traditional medical services and long-term care services. Many of these services, even when covered by traditional insurance, may be difficult to access in our fragmented healthcare system. Although a combination of Medicare and Medicaid, programs that in theory should provide equal access to black and white older people, cover many of these services, there are substantial racial disparities in healthcare use by frail older people. For example, black patients use fewer skilled home care services and nursing home care despite experiencing higher rates of functional disability. 16, [25] [26] [27] As a result, providing comprehensive access to care and coordination of services may improve health outcomes in this population.
This study sought to determine the relationship between race and mortality in frail community-dwelling older people who have obtained access to the comprehensive services and coordination of care provided by the Program of All-inclusive Care for the Elderly (PACE). 28, 29 PACE is a healthcare system that provides comprehensive services for frail community-dwelling older people who meet state criteria for nursing home placement but choose to live at home. PACE provides for all medically indicated care, including all hospitalizations, outpatient medical services, medications, physical and occupational therapy, transportation, adult day health, home health aids, and durable medical equipment, including hearing and vision aids. An interdisciplinary team, which includes primary care physicians, social workers and physical and occupational therapists, coordinates these services. These services are provided at no additional cost beyond the PACE premium, for which, for most patients, Medicaid and Medicare fully pay. PACE is an important model for caring for our aging population 28 and provides an opportunity to better understand racial disparities in health care.
METHODS

Subjects and Data Source
The 3,113 black and white patients that enrolled in the PACE demonstration sites between January 1, 1990, and December 31, 1996 were eligible for this study. Patients identified as Hispanic and of other races were excluded from the analysis because they were not well represented across all of the 12 PACE demonstration sites. The 163 white patients and 89 black patients who were missing baseline data on comorbid conditions or dependence in activities of daily living (ADLs) were excluded. In the final sample of 2,861 patients, 2,002 were white, and 859 were black.
Data-PACE, the data source for these analyses, contained a uniform set of demographic, functional, and clinical data collected by all sites. 30 Detailed procedure manuals outlined the guidelines for data collection, with specific definitions and protocols for each data element. The data collection staff participated in centralized training, and staff from the coordinating center visited each PACE site yearly to assure the quality of the data collection.
Measurement of Race and Survival Time
Race was determined by patient's self-report or caregiver's report on enrollment. Survival time was defined as the time from the initial health assessment to death or the end of the study period on December 31, 1997, at which point surviving patients were censored. For the 137 white patients and 132 black patients who disenrolled from PACE before death, vital status and date of death were determined using the National Death Index.
Measurement of Potential Confounders
Staff physicians recorded the presence of major comorbid conditions based on each patient's enrollment history and examination. Each site's nursing staff assessed each patient's functional status at the time of the patient's enrollment and at approximately 3-month intervals. This included the degree of dependence in walking and the five ADLs: bathing, dressing, toileting, transferring, and eating. 31 For walking and each of the five ADLs, nurses assessed patients as independent, needing some help or supervision (partial dependence), or needing complete help and supervision (fully dependent) based on their clinical assessment at enrollment. 30 A combined ADL score (0-10) was constructed by assigning 0 points for total dependence, 1 point for partial dependence, and 2 points for independence. Nurses assessed the degree of bowel and bladder incontinence, visual and hearing impairment, and communication impairment. 30 Cognitive status was assessed using the 10-item Short Portable Mental Status Questionnaire (SPMSQ). 32 Each site's social work staff collected demographic data such as age, sex, and caregiver status. Caregiver status was described as having no caregiver, having a household caregiver, and having a nonhousehold caregiver.
Analyses
The baseline characteristics of black and white subjects were compared using the t test for continuous variables and chi-square tests for categorical variables. The KaplanMeier method was used to create 5-year survival curves. The relationship between race and mortality was examined using Cox proportional hazards analyses. Two different models were used: an unadjusted model and an adjusted model that included a number of potential confounders that were felt likely to be associated with mortality. 33 The presence of each of the following comorbid conditions was adjusted for as determined by the staff physicians' history and physical enrollment to PACE: malignant neoplasm, coronary artery disease, congestive heart failure, cerebrovascular disease, chronic obstructive pulmonary disease, diabetes mellitus, hypertension, visual impairment, hearing impairment, depression, and dementia. To control for functional status, the ADL score, the SPMSQ score, and indicator variables for walking, bowel or bladder incontinence, and communication impairment were included. This model also included the following demographic characteristics: age, sex, PACE site, marital status, years of education, caregiver status, and Medicaid eligibility. Information on ADLs and comorbid conditions was available for all patients in the final sample. When data were missing for educational level, marriage status, Medicaid eligibility, incontinence, cognitive status (SPMSQ), or caregiver status, indicator variables were substituted for categorical or nominal variables and mean data for continuous variables. None of these data elements were missing for more than 5% of patients. The C statistic for the adjusted model was 0.71.
Adjusted risk differences in mortality between black and white patients across several subgroups were adjusted. To determine whether the relationship between race and mortality was affected by demographic characteristics, subgroups based on age ( Ͻ or Ն 80), sex, and education ( Յ or Ͼ 9 years) were chosen. To determine whether there was an interaction between race and disability, patients were analyzed by ADL score ( Յ or Ͼ 7) and a diagnosis of dementia. P -values were calculated for interaction terms to determine whether the hazard ratios for mortality differed across subgroups.
Two further analyses were performed to investigate the possibility that survival differences between black and white patients were due to different rates of enrollment for end-oflife care. 33 First, the adjusted model was repeated after excluding patients with a diagnosis of malignant neoplasm. Second, the hazard ratios were analyzed separately for mortality for the first year after enrollment and the time period after the first year using the adjusted model. A P -value for time interaction was calculated to determine whether mortality differed before and after 1 year of enrollment.
Because functional status is an important predictor of mortality in older people, 25 functional status changes were compared in patients who survived 1 year after enrollment to determine whether the prognosis of black patients changed relative to that of white patients after the first year of PACE enrollment. Functional status changes were determined by comparing ADL scores on enrollment with scores 1 year after enrollment. ADL scores were categorized as worse, same, or better and analyzed using the chisquare test.
RESULTS
On enrollment, the mean age of PACE patients was 79. Baseline characteristics are shown in Table 1 . Although black patients were younger than white patients, they had worse functional status (as measured by ADL score), worse cognitive status (as measured by SPMSQ), and higher rates of dementia. The baseline prevalence of diabetes mellitus, hypertension, and cerebrovascular disease was higher in black patients, whereas rates of malignancy, depression, congestive heart failure, and chronic obstructive pulmonary disease were higher in white patients.
Eight hundred twenty white patients and 260 black patients died during the follow-up period. In the first year, 338 white patients and 117 black patients died. Survival for black and white patients was 88% and 86% at 1 year, 67% and 61% at 3 years, and 51% and 42% at 5 years, respectively (Figure 1 ). The unadjusted hazard ratio (HR) for mortality for black patients compared with white patients was 0.77 (95% confidence interval (CI) ϭ 0.67-0.89) ( Table 2 ). After adjusting for age, sex, functional status, cognitive function, site, and other demographic characteristics and major comorbid diagnoses, black patients continued to have lower rates of mortality than white patients (HR ϭ 0.77; 95% CI ϭ 0.65-0.93). Results were similar when patients with a diagnosis of a malignant neoplasm were excluded. Mortality rates were almost identical for black and white patients for the first year after PACE enrollment (adjusted HR ϭ 0.97; 95% CI ϭ 0.72-1.31). However, after 1 year, black patients had persistently lower mortality rates than white patients (adjusted HR ϭ 0.67; 95% CI ϭ 0.54-0.85). The difference in hazard ratios between the first year and the subsequent follow-up period was significant ( P -value for the time interaction term Ͻ .001).
Black patients had lower mortality rates than white patients in all subgroups, including age less than 80 or 80 and older, male or female, ADL score less than or equal to the median or greater than the median, with or without dementia and education of 9 years or less or more than 9 years. The differences in hazard ratios were not statistically different across any of the subgroups analyzed (all interaction term P -values Ͼ .05). Black patients had better functional status trends than white patients during the first year after enrollment in PACE. ADL scores were available for more than 95% of the patients who were alive and enrolled at 1 year. At 1 year, 34% of black patients had worse ADL scores, 34% had the same ADL scores, and 32% had improved ADL scores; 39% of white patients had worse ADL scores, 33% had the same ADL scores, and 27% had improved ADL scores ( P ϭ .02).
DISCUSSION
This study found that black patients enrolled in PACE had better survival rates than white patients. This survival advantage emerged about 1 year after enrollment in PACE and persisted after adjustment for potential confounders.
The delay between enrollment and the emergence of a survival advantage in black patients is indirect evidence that the survival advantage was related to enrollment in PACE, although this survival advantage for black patients could be due to other unmeasured confounders or measurement bias.
PACE enrollment could have resulted in better survival of black patients if they had less access to care than white patients before PACE enrollment and if this poor access elevated the baseline risk of mortality. Previous barriers to care could explain why black patients who enroll in PACE are more disabled despite being younger. Although no specific data on access to care before enrollment in PACE are provided, previous studies have documented lower use of health care by black Medicare beneficiaries. 4, 6, 12 Any additional risk of mortality in black patients that is associated with previously worse access to care might be partially reversed once they receive improved access to and coordination of care. In contrast, white patients in PACE may have had previously better access to care than black patients, and their risk for mortality may be less reversible because it reflects disease advancement that occurs despite access to care. Consider the example of two patients enrolled with equal disability due to stroke. The first patient has never had physical therapy, home health aides, or good medical treatment and might experience better outcomes in PACE than the second patient, who is disabled despite these previous interventions. This theory is consistent with the finding that black patients had better functional status changes than white patients after receiving PACE services for 1 year. 34 Other unmeasured confounders might possibly have contributed to the black survival advantage observed. This would have required that the black patients were healthier at the time of enrollment in a way that was not measured by comorbid conditions, functional status, or demographic characteristics. For example, black patients would have an inherent survival advantage if they were enrolled primarily for custodial care and white patients were enrolled primarily for end-of-life care. Although black patients in PACE are more likely to select aggressive interventions, 35 it is important to note that they experience fewer hospitalizations than white patients in PACE. 34 Also, the survival advantage for black patients persisted when patients with malignant neoplasms were excluded. In addition, if the survival advantage was due to confounders that were unmeasured at enrollment (disease severity or treatment preferences), the survival advantage should have been present throughout the follow-up period, whereas it emerged only after 1 year of enrollment.
Biases in the measurement of comorbid conditions, functional status, and demographic characteristics could possibly account for the survival advantage observed for black patients in the adjusted analysis. For example, an overestimation of baseline morbidity or an underestimation of socioeconomic status (SES) in the black cohort could result in an overestimation of adjusted survival rates of black patients. An overestimation of baseline morbidity in black patients would have occurred if comorbid diagnoses and functional impairment were systematically overestimated in black patients or if the measures themselves were culturally biased. 36 However, the findings of higher baseline morbidity in the black patients are consistent with the higher levels of age-adjusted morbidity found in other samples of black patients. 16, [25] [26] [27] Likewise, it is more likely that the use of education as a surrogate for SES overestimates the SES of black patients. 37 Finally, these biases could not explain why the observed adjusted survival advantage emerges only after 1 year of enrollment in PACE, because such biases should have affected adjusted mortality throughout the follow-up period. Although most studies demonstrate worse health outcomes for black patients than white patients, a few studies have also observed better survival of black patients. Prior studies observing black survival advantages have tended to occur in three settings: in patients after acute hospitalization, 6, 18, 19, 21 in patients enrolled in Medicare hemodialysis, 11, 20, 23 and in patients enrolled in the Department of Veterans Affairs. 19 The common thread linking these studies and the current study is that the cohorts were defined by patients presenting for treatment rather than by disease alone. When survival is compared among patients presenting for treatment, those with previously poor access to care may have better risk-adjusted outcomes because their baseline risk is more reversible. Further research should focus on determining prior access to care in settings where black survival advantages have been observed. This study has several limitations. The classification of subjects as white or black is overly simplistic and fails to account for the heterogeneity in each group. 38 There is also considerable variation in the number of black and white patients across the sites. Although site was included in the model, previous study has shown significant variation in hospitalization across sites in a similar population. 34 Although the authors were able to adjust for several important clinical variables, they did not have information regarding the severity of comorbid conditions or the causes of death. Also, they did not have information about other predictors of mortality such alcohol, tobacco, or substance abuse.
In conclusion, black patients in PACE, a health system offering access to comprehensive services and coordination of care, experienced lower mortality rates than white patients in PACE. Although white patients also benefited from enrollment in PACE, it is possible that enrollment in PACE may have reversed some of the sequelae of worse access to care and resulted in a black survival advantage. Although it remains unclear whether black patients may have specifically benefited from increased access to a particular service provided by PACE or from the interdisciplinary model that PACE uses, a black survival advantage in a frail, predominately low-income, older population would suggest that it is never too late to improve access to care. However, the fact that black patients were more disabled on enrollment than white patients, despite being younger, is evidence of continued disparities in health outcomes in the United States. Future research will be needed to determine whether improving access to health care can reverse the morbidity and mortality that result from poor access to care.
